Aurora Mirabile, Consultant Medical Oncologist, Head of Head and Neck Cancer Diagnosis and Treatment Section, Division of Otorhinolaryngology, IRCCS Ospedale San Raffaele, shared on LinkedIn:
“ESMO Congress 2026 is underway in Madrid!
Exciting advances in head and neck, thyroid, and non-melanoma skin cancers are taking center stage, with new evidence and emerging therapeutic strategies shaping the future of oncology.
The infographic below highlights some of the key studies and topics featured at this year’s congress:
- Novel immunotherapy combinations, bispecific antibodies, and ADCs in head and neck cancer.
- Emerging targeted therapies and precision medicine approaches in thyroid cancer.
- Neoadjuvant immunotherapy and innovative treatment strategies in cutaneous squamous cell carcinoma (cSCC).
- The growing importance of biomarkers, treatment personalization, and quality of life.
Beyond new drugs and clinical trial results, the real challenge remains translating scientific progress into meaningful benefits for our patients.
Looking forward to inspiring discussions, sharing experiences with colleagues, and bringing new insights into our daily clinical practice!”
You can also read: Gilberto Lopes: Key Insights from ESMO 2026
